Literature DB >> 27816404

Acute renal failure after intravitreal antivascular endothelial growth factor therapy.

Yu-Fang Huang1, Shih-Jen Chen2, Min-Yen Hsu3, De-Kuang Hwang4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27816404     DOI： 10.1016/j.jfma.2016.09.010

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN： 0929-6646            Impact factor:   3.282


× No keyword cloud information.
  3 in total

1.  Proteinuria and Renal Dysfunction after Intravitreal Injection of Bevacizumab in Patients with Diabetic Nephropathy: A Prospective Observational Study.

Authors:  Sina Bagheri; Banafshe Dormanesh; Mehrdad Afarid; Mohammad Mahdi Sagheb
Journal:  Galen Med J       Date:  2018-10-16

2.  Evaluation of long-term intravitreal anti-vascular endothelial growth factor injections on renal function in patients with and without diabetic kidney disease.

Authors:  Rachael Ann O'Neill; Patrick Gallagher; Tricia Douglas; Julie-Anne Little; Alexander Peter Maxwell; Giuliana Silvestri; Gareth McKay
Journal:  BMC Nephrol       Date:  2019-12-26       Impact factor: 2.388

3.  Risk of dialysis in patients receiving intravitreal anti-vascular endothelial growth factor treatment: a population-based cohort study.

Authors:  Shun-Fa Yang; Yu-Chen Su; Chen-Chee Lim; Jing-Yang Huang; Sheng-Min Hsu; Li-Wha Wu; Yi-Sheng Chang; Jia-Horung Hung
Journal:  Aging (Albany NY)       Date:  2022-06-20       Impact factor: 5.955
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.